USFDA4 Oct 2025, 05:31 pm
FDC Ltd Receives ANDA Approval from U.S. FDA for Pilocarpine Hydrochloride Ophthalmic Solution
AI Summary
FDC Ltd has announced that it has been granted ANDA approval by the United States Food and Drug Administration (U.S.FDA) for Pilocarpine Hydrochloride Ophthalmic Solution USP, 1%, 2%, and 4% (15 mL). This is a significant achievement for the company, as it continues to expand its presence in the global market.
Key Highlights
- FDC Ltd has received ANDA approval from U.S. FDA for Pilocarpine Hydrochloride Ophthalmic Solution USP, 1%, 2%, and 4% (15 mL)
- This approval marks a significant milestone for the company in its efforts to expand its global footprint
- The company's commitment to quality and regulatory compliance has been recognized by the U.S. FDA
- FDC Ltd's diversified product portfolio continues to grow with this approval
- The company's focus on ophthalmic solutions is further strengthened with this approval